Next Article in Journal
Inhibition of let-7c Regulates Cardiac Regeneration after Cryoinjury in Adult Zebrafish
Next Article in Special Issue
The Functions of Long Non-Coding RNA during Embryonic Cardiovascular Development and Its Potential for Diagnosis and Treatment of Congenital Heart Disease
Previous Article in Journal
An Update on the Tissue Renin Angiotensin System and Its Role in Physiology and Pathology
Previous Article in Special Issue
A Hearty Dose of Noncoding RNAs: The Imprinted DLK1-DIO3 Locus in Cardiac Development and Disease
Article Menu

Export Article

Open AccessReview

The Role of Non-Coding RNA in Congenital Heart Diseases

Cardiovascular Development Group, Department of Experimental Biology, University of Jaen, 23071 Jaen, Spain
Author to whom correspondence should be addressed.
J. Cardiovasc. Dev. Dis. 2019, 6(2), 15;
Received: 26 February 2019 / Revised: 24 March 2019 / Accepted: 26 March 2019 / Published: 1 April 2019
(This article belongs to the Special Issue Non Coding RNAs in the Cardiovascular System)
PDF [899 KB, uploaded 9 May 2019]


Cardiovascular development is a complex developmental process starting with the formation of an early straight heart tube, followed by a rightward looping and the configuration of atrial and ventricular chambers. The subsequent step allows the separation of these cardiac chambers leading to the formation of a four-chambered organ. Impairment in any of these developmental processes invariably leads to cardiac defects. Importantly, our understanding of the developmental defects causing cardiac congenital heart diseases has largely increased over the last decades. The advent of the molecular era allowed to bridge morphogenetic with genetic defects and therefore our current understanding of the transcriptional regulation of cardiac morphogenesis has enormously increased. Moreover, the impact of environmental agents to genetic cascades has been demonstrated as well as of novel genomic mechanisms modulating gene regulation such as post-transcriptional regulatory mechanisms. Among post-transcriptional regulatory mechanisms, non-coding RNAs, including therein microRNAs and lncRNAs, are emerging to play pivotal roles. In this review, we summarize current knowledge on the functional role of non-coding RNAs in distinct congenital heart diseases, with particular emphasis on microRNAs and long non-coding RNAs. View Full-Text
Keywords: non-coding RNA; microRNAs; lncRNAs; congenital heart disease non-coding RNA; microRNAs; lncRNAs; congenital heart disease

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Dueñas, A.; Expósito, A.; Aranega, A.; Franco, D. The Role of Non-Coding RNA in Congenital Heart Diseases. J. Cardiovasc. Dev. Dis. 2019, 6, 15.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
J. Cardiovasc. Dev. Dis. EISSN 2308-3425 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top